Flea ultraspiracle nucleic acid molecules
The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
1. An isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of:
(a) a nucleic acid sequence that encodes a protein comprising SEQ ID NO:33, SEQ ID NO:70 or SEQ ID NO:71; and,
(b) a nucleic acid sequence fully complementary to a nucleic acid sequence of(a).
2. A recombinant molecule comprising a nucleic acid molecule as set forth in claim 1 operatively linked to a transcription control sequence.
3. A recombinant cell comprising a nucleic acid molecule as set forth in claim 1 .
4. An isolated nucleic acid molecule selected from the group consisting of:
(a) a nucleic acid sequence comprising SEQ ID NO:32 or SEQ ID NO:35; and,
(b) a nuclei acid sequence fully complementary to a nucleic acid sequence of (a).
5. A recombinant molecule comprising a nucleic acid molecule as set forth in claim 4 operatively linked to a transcription control sequence.
6. An isolated nucleic acid molecule consisting of a nucleic acid sequence selected from the group consisting of:
(a) a nucleic acid sequence encoding a protein consisting of SEQ ID NO:33, SEQ ID NO:70 or SEQ ID NO:71; and
(b) a nucleic acid sequence consisting of SEQ ID NO:32, SEQ ID NO:34 or SEQ ID NO:35; and
(c) a nucleic acid sequence fully complementary to the nucleic acid sequence of (a) or (b).